Vasodilators and inotropes provide symptomatic relief for decompensated heart failure
- 14 Downloads
KeywordsAcute Pancreatitis Dobutamine Levosimendan Milrinone Decompensated Heart Failure
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- 7.Mills RM, LeJemtel TH, Horton DP, et al. Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group. J Am Coll Cardiol 1999 Jul; 34(1): 155–62PubMedCrossRefGoogle Scholar
- 9.Young JB. Vasodilation in the Management of Acute Congestive Heart Failure (VMAC) study results [oral presentation]. 73rd Scientific Sessions of the American Heart Association; 2000 Nov 12–15: New OrleansGoogle Scholar
- 10.Lowes BD, Simon MA, Tsvetkova TO, et al. Inotropes in the beta-blocker era. Clin Cardiol 2000; 23 Suppl. III: 11–6Google Scholar
- 11.Loh E. Maximizing management of patients with decompensated heart failure. Clin Cardiol 2000; 23 Suppl. III: 1–5Google Scholar
- 13.Follath F, Cleland JGF, Just H, et al. Efficacy and safety of intravenous levosimendan in severe low-output heart failure [abstract no. 3406]. Circulation 1999; 100(18) Suppl. I: I–646Google Scholar
- 14.Simdax — Orion Pharma. Dosing [online]. Available from: URL: http://www.simdax.com/defaultl.asp?id=4200 [Accessed Feb 2001]
- 17.Diller PM, Smucker DR, David B. Comanagement of patients with congestive heart failure by family physicians and cardiologists: frequency, timing, and patients characteristics. J Fam Pract 1999; 48: 177–9Google Scholar
© Adis International Limited 2002